Other News

Zynex Announces 2019 First Quarter Earnings

ENGLEWOOD, Colo., April 30, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2019. First Quarter Financial Results Summary:For the first […]

Omron Healthcare Launches Complete™, the First Blood Pressure Monitor with EKG Capability in a Single Device, for Retail Sale

LAKE FOREST, Ill., May 1, 2019 /PRNewswire/ — Omron Healthcare, Inc., the number one doctor and pharmacist recommended blood pressure brand, today launched Complete™, the first blood pressure monitor with EKG capability in a single device, for retail sale in the U.S. online at OmronHealthcare.com. Complete recently received FDA clearance as a medical device. […]

Medtronic Receives FDA Approval for World’s First Quadripolar Active Fixation Left Heart Lead

DUBLIN – May 1, 2019 – Medtronic plc (NYSE:MDT) announced it has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability(TM) Quad MRI SureScan(TM) left heart lead. Paired with Medtronic quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) and -pacemakers (CRT-P), the Attain Stability Quad lead is the only active-fixation left […]

NuCryo Vascular Announces Series B Financing and the Launch of its Extended PolarCath Catheter

SAN JOSE, Calif.–(BUSINESS WIRE)–NuCryo Vascular, the manufacturer and marketer of the PolarCath Balloon Dilatation System, announced today that the company is raising a Series B round of financing and is launching its Extended PolarCath Balloon Dilatation Catheter. The Series B financing will provide the necessary working capital to support the […]

VivaQuant Receives FDA 510(k) Clearance for its RX-1 Rhythm ExpressTM Arrhythmia Device

ST. PAUL, Minn.–(BUSINESS WIRE)–VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device. RX-1 continuously monitors a patient’s ECG as they go about their normal daily activities, identifies arrhythmias, and communicates the information to […]

Murj 2.0 Gives Cardiologists a 360-Degree Implantable Device Patient View

SANTA CRUZ, Calif., April 30, 2019 (GLOBE NEWSWIRE) — Murj, the digital healthcare company providing Software-as-a-Service (SaaS) cardiac implantable electronic device (CIED) management, announced today the immediate availability of Murj 2.0. This revolutionary implantable cardiac device management software empowers clinicians to deliver superior patient care in ways never before possible. […]

Clinical Trial Results from MyoKardia’s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine

SOUTH SAN FRANCISCO, Calif., April 30, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious cardiovascular diseases, today announced the publication of results from the company’s Phase 2 PIONEER-HCM study of mavacamten in an upcoming issue of […]

Precision Optics Corporation, Inc. Announces Receipt of $2.2 Million Order For Custom Designed Cardiovascular Endoscope

GARDNER, Mass., April 29, 2019 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (OTCQB: PEYE) today announced that it has received a follow-on order totaling $2,216,000 from CardioFocus, Inc. for the manufacture of a cardiovascular endoscope to support the HeartLight Endoscopic Ablation System. Deliveries are scheduled to be made over two […]